AFP and hepatocellular carcinoma: For example, although Zhang et al reported that AFP plus ultrasound surveillance every 6 months in a population with HBV infection significantly reduced HCC mortality by 37% compared with a non-screened population with HBV infection [39], another similar study showed that HBV carriers with periodic AFP screening had no survival benefit compared to those without screening [41].